Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers

D. Nguyen X. Wei Xianzhang Meng Laura Alexander Kristin Ryan Seong Jang

DOI PubMed Semantic Scholar